[Research Report] The compartment syndrome monitoring devices market size is expected to grow from US$ 186.7 million in 2022 to US$ 380.2 million by 2031; it is estimated to register a CAGR of 7.2% from 2022 to 2031.

Analyst’s ViewPoint

The compartment syndrome monitoring devices market analysis explains market drivers such as the rising accidents resulting in compartment syndrome and the high utility of anabolic steroids, which are standalone factors responsible for influential market growth. Further, technological advancement is expected to introduce new trends in the market during 2022–2031. Based on type, the abdominal compartment syndrome segment held a larger market share in 2022. Based on product, the global compartment syndrome monitoring devices market is bifurcated into disposable and equipment. The equipment segment will account for a major share of the segment growth in 2022. Furthermore, based on end users, the global compartment syndrome monitoring devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment will account for the largest compartment syndrome monitoring devices market share.

Compartment syndrome is a serious condition when muscle pressure reaches dangerous levels. This pressure decreases blood flow, preventing nourishment and oxygen from reaching nerve and muscle cells. Compartment syndrome symptoms involve swelling or bleeding occurring within a compartment. There are two major types of compartment syndrome. These involve acute compartment syndrome and chronic (exertional) compartment syndrome.

Market Insights

Rising Accidents Results in Compartment Syndrome

Compartment syndrome after a car accident is a painful condition occurring when high levels of pressure are built inside compartments in muscles. This pressure results in muscle and nerve damage because the components do not stretch, preventing blood from flowing into the area where muscles have swollen. For example, motor vehicle accidents are common worldwide due to inclement weather, poor road conditions, construction zones, and impaired or reckless drivers. Injuries associated with car accidents can cause scratches and bruises, proving fatal, resulting in compartment syndrome, swelling, and bleeding in a compartment, causing extra pressure. Such compartment pressure prevents blood flow to the muscles and nerves, resulting in significant pain among the victims of motor accidents. Therefore, manufacturers design compartment pressure devices that allow fluid withdrawal, and these intercompartmental pressure devices can be used to diagnose the syndrome. These devices are regulated by the 510 (k) pathway and are cleared for marketing worldwide. Such aforementioned factors are responsible for influential market growth during 2021-2031.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Compartment Syndrome Monitoring Devices Market: Strategic Insights

Market Size Value in	US$ 186.7 million in 2022
Market Size Value by	US$ 380.2 million by 2030
Growth rate	CAGR of 7.2% from 2022 to 2030
Forecast Period	2022-2030
Base Year	2022

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

High Utility of Anabolic Steroids

Bodybuilders frequently use anabolic steroids to achieve a rapid increase in muscle mass and strength, resulting in complications. The main reason for the uptake of these anabolic steroids is to enhance muscle mass and strength. In the majority of cases, the countries selling anabolic steroids are regulated. However, the black market makes acquisitions with little control or regulation. Therefore, anabolic steroid uptake is linked to several complications, including neuromuscular complications such as mononeuropathies and compartment syndromes. Additionally, the steroid injections also cause localized rhabdomyolysis in the injection site, contributing to compartment syndrome development. 

This is well understood by a case study of a 19-year-old male with no past medical history who presented to the Emergency Department (ED) due to right pain and swelling. The patient performed frequent sessions of resistance exercises focusing on muscle hypertrophy. The person was also taking daily oral and injectable anabolic-androgenic steroids mixture (testosterone, trenbolone, winstrol, boldenone, clemetrol, oxandrolone, and triiodothyronine) for the last twelve weeks. Injection of anabolic steroid mixtures included the upper limbs, buttocks, and lower limbs. The examination revealed a slightly edematous and warm right leg with ankle dorsiflexion limitation. Also, laboratory findings revealed that leucocytosis has increased with elevated creatinine kinase and a slight hepatic cytolysis pattern. The patient was discharged later from the Emergency Department (ED) with analgesia and indication to rest, cryotherapy, and stop steroids. Therefore, the high utility of anabolic steroids accelerates the demand for compartment syndrome monitoring devices, ultimately driving the market growth during 2021-2031.

Future Trend

Technological Advancements

Technological advancements have improved the precision and effectiveness of compartment syndrome monitoring devices.  The technological advances have resulted in the opening of new avenues for market growth.  The ultrasonic system to assess compartment syndrome is one such example.  NASA Langley Research Center has developed an ultrasonic system to assess compartment syndrome.  This ultrasonic system provides non-invasive and quick testing for compartment syndrome and delivers potential outcomes.  The technology utilizes the "ultrasonic waves to categorize pressure build-up in body compartment" technique.  This technique assesses the body compartment configuration and identifies the effect of pulsatile components on at least one compartment dimension.  The apparatus is used to measure excess pressure in the body compartment, having components for imparting ultrasonic waves such as transducer, placing transducer to impart ultrasonic waves, capturing the reflected imparted ultrasonic waves, converting the electrical signals, and mathematically manipulating the output signals. Also, the market is witnessing continuous technological advancements, such as the development of advanced intra-compartmental pressure (IPC) monitoring devices, such as non-invasive ICP monitoring devices, continuous monitoring systems, and smart wearables. Such product innovation aimed to improve the diagnosis and management of compartment syndrome. Such technological advancements enhanced the market growth of the compartment syndrome monitoring devices market during 2021-2031.

Report Segmentation and Scope

Type-Based Insights

Based on type, the compartment syndrome monitoring devices market is segmented as acute, chronic, and abdominal compartment syndrome. The abdominal compartment syndrome segment held a larger market share in 2022. Abdominal compartment syndrome refers to organ dysfunction caused by intra-abdominal hypertension. The symptoms are underrecognized because they primarily affect patients who are already ill and whose organ dysfunction may be incorrectly ascribed to the progress of the primary illness. According to the American Roentgen Ray Society, ARRS 2023 report, abdominal compartment syndrome is significant, ranging between 60% and 70%, and the poor healthcare outcome relates not only to abdominal compartment syndrome itself but also to concomitant injury and hemorrhagic shock. Therefore, the currently accepted treatment for abdominal compartment syndrome is decompressive laparotomy. Also, other methods of reducing the intraabdominal pressure include drainage of fluid collection and muscle relaxation. Therefore, the availability of treatment options for abdominal compartment syndrome is a standalone factor responsible for segment growth, ultimately driving the compartment syndrome monitoring devices market during 2021-2031.

Product-Based Insights

Based on product, the global compartment syndrome monitoring devices market is bifurcated into disposable and equipment.

End User-Based Insights

Based on end users, the global compartment syndrome monitoring devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals segment will account for the largest compartment syndrome monitoring devices market share. Rising patients suffering from compartment syndrome are the contributing factors responsible for the growing demand for monitoring devices in hospitals. Additionally, surging cases of abdominal compartment syndrome in acute care hospitals raise the utilization of compartment syndrome monitoring device products in hospitals.

Further, the hospital segment's considerable growth is primarily attributed to the availability of accurate compartment pressure measurement equipment and the rising prevalence of intra-abdominal hypertension (IAH). IAH directly impacts abdominal organs, including the liver and kidneys, and has the potential to lead to organ dysfunction. This condition is increasingly prevalent among patients receiving mechanical ventilation. Therefore, hospitals providing an efficient and practical approach to measuring intra-abdominal pressure management and validation results in segment growth, ultimately driving the market growth during 2021-2031.

Regional Analysis

The North American compartment syndrome monitoring devices market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the new product launches by the top manufacturers as a standalone factor positively influencing the market's growth. Mikro-Cath Pressure Catheter by Miller is one such example. The Mikro-Cath Pressure Catheter has been used to access chronic exertional compartment syndrome, demonstrating that these sensors work well to measure compartment pressure with attached sensors. These sensors are well-tolerated with the flexible cable, allowing walking and running on a treadmill. The pressure sensor at the tip of the catheter is a quick and easy setup of accessories for collecting compartment pressure. Such significant development by the manufacturers enhances the market growth during 2021-2031.

Potrero Medical's "AccuTab" is another example of compartment syndrome. The AccuTab can be mounted on the intravenous (IV) pole, providing maximum flexibility where the monitor resides, reducing clinical exposure, and identifying early-stage renal performance changes. Such innovative product launches by the players enhance the market growth of compartment syndrome in the US, thereby dominating the market growth from 2021 to 2031.

Likewise, Asia Pacific will account for the highest CAGR for the compartment syndrome monitoring devices market for the forecast period 2022-2031. In China, during the outbreak of COVID-19 in 2021, timely diagnosis was a crucial step for infection control. The rising prevalence of infectious diseases in China in 2021 accelerated the demand for compartment syndrome monitoring devices as they possess high sensitivity for diagnosis and are potential tools for COVID-19 detection. The rising prevalence of infectious diseases like COVID-19 raises demand for compartment syndrome monitoring devices, thereby dominating the segment growth for the forecast period 2022-2031.

The report profiles leading players operating in the global compartment syndrome monitoring devices market. These include Miller, Inc., Medline Industries, Inc., Becton, Dickinson, and Company, Potrero Medical, ConvaTec Group, Biometrix Ltd., Spiegelberg GmbH & Co. KG., MY01, Inc., Terumo Corporation, Raumedic AG, and other market participants. The companies involved in compartment syndrome monitoring devices are involved in new organic and inorganic developments focusing on new product launches, mergers, and collaboration.

In January 2023, ConvaTec Inc. announced the launching of the "ConvaFoam," a family of advanced foam dressings designed to address the needs of healthcare providers and patients. ConvaFoam is used as a spectrum of wound types at any stage of the wound journey, making it a simple dressing choice for wound management and skin protection. Also, the product is specifically designed to help address the silent epidemic by removing the complexity of wound care and offering healthcare providers and patients more than just a dressing.

In April 2021, MY01 Inc. announced US Food and Drug Administration (USFDA) approval for acute compartment syndrome (ACS) with Bluetooth capabilities. MY01 continuous compartment pressure monitor uses proprietary and innovative technologies to deliver a highly reliable, accurate continuous pressure microsensor directly within the muscle.

Company Profiles

• Miller, Inc.
• Medline Industries, Inc.
• Becton, Dickinson, and Company
• Potrero Medical
• ConvaTec Group
• Biometrix Ltd.
• Spiegelberg GmbH & Co. KG.
• MY01, Inc.
• Terumo Corporation
• Raumedic AG